Oral bisphosphonate use and colorectal cancer incidence in the Women's Health Initiative.

@article{Passarelli2013OralBU,
  title={Oral bisphosphonate use and colorectal cancer incidence in the Women's Health Initiative.},
  author={M N Passarelli and Polly A Newcomb and Andrea Z LaCroix and Dorothy S Lane and Gloria Y. F. Ho and Rowan Chlebowski},
  journal={Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research},
  year={2013},
  volume={28 9},
  pages={2043-8}
}
Bisphosphonates are widely prescribed to increase bone density in postmenopausal women with osteopenia or osteoporosis. Aminobisphosphonates have numerous anticancer properties and reduce bone metastases in cancer patients. Several studies, including the Women's Health Initiative (WHI), have found that use of oral bisphosphonates is associated with reduced risk of developing breast cancer, but less is known about associations with other common malignancies in women such as colorectal cancer… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 2 times. VIEW TWEETS

Similar Papers

Loading similar papers…